HEXO Corp. has completed its previously announced at-the-market equity program. Under the ATM Program, the Company sold an aggregate of 33,921,979 common shares between June 18, 2020 and July 31, 2020 through the Toronto Stock Exchange, the New York Stock Exchange and other marketplaces on which the common shares are listed, quoted or otherwise traded. The common shares were sold at prevailing market prices for gross proceeds of C$17,248,047 and US$12,751,168, or total gross proceeds of C$34,497,272 after applying applicable US$-C$ exchange rates.
Distributions of the common shares through the ATM Program were made pursuant to the terms of an equity distribution agreement dated June 16, 2020 among the Company, ATB Capital Markets Inc., as Canadian agent, and Oppenheimer & Co. Inc., as U.S. agent. The Company expects to use the net proceeds from the ATM Program for general corporate purposes, which may include: (i) working capital; (ii) capital expenditures; and (iii) debt repayments.
HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.
